For over 20 years, drug manufacturers have relied on Drug GMP Report for the latest on FDA’s interpretation and enforcement of cGMPs and Quality Systems Regulation — information you need to stay in compliance. Each monthly issue brings you the latest on FDA enforcement trends and warning letters, track and trace developments, international regulations and more. You’ll also get the latest on inspection hot spots, data integrity issues, EU pharmacovigilance initiatives, harmonization efforts and evolving trends in drug GMP enforcement. Plus, every issue, you get links to critical documents such as draft and final guidances, Form 483s, warning letters, proposed rules, full text of proposed legislation and many more.

Drug GMP Report is published 12 times a year.

This daily electronic briefing delivers coverage of developments at the FDA, FTC, HHS and other key agencies and decision-making bodies that affect the pharmaceutical industry around the world. Each issue gives you the most up-to-date news on top issues, such as patent exclusivity, market globalization enforcement, EU pharmacovigilance, new inspection trends, advertising practices, FDA warning letters, recalls, approvals and more. It’s the fastest, most reliable way to make sure you’re an industry expert.

Drug Industry Daily is published 250 times a year.